Voltaren Emulgel Original

Voltaren Emulgel is a well-known topical analgesic used for the relief of muscle and joint pain. Originally developed in Switzerland, the active ingredient, diclofenac, was first synthesized by Ciba-Geigy, which later became part of Novartis.

Today, Voltaren is a flagship brand under Haleon, a global leader in consumer health. The product is manufactured in various high-tech pharmaceutical facilities around the world, including locations in Europe (such as Germany and Switzerland), the Americas, and Asia, depending on the specific regional market and distribution logistics.

Ownership of the brand transitioned from Novartis to a joint venture with GSK, eventually spinning off into the independent entity Haleon in 2022. It remains one of the most trusted over-the-counter pain management solutions internationally.